CT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors
Open Access
- 29 June 2015
- journal article
- research article
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2015, 1-8
Abstract
Purpose. To study radiological response to stereotactic radiotherapy for focal liver tumors.Materials and Methods. In this IRB-approved, HIPAA-compliant study CTs of 68 consecutive patients who underwent stereotactic radiotherapy for liver tumors between 01/2006 and 01/2010 were retrospectively reviewed. Two independent reviewers evaluated lesion volume and enhancement pattern of the lesion and of juxtaposed liver parenchyma.Results. 36 subjects with hepatocellular carcinoma (HCC), 25 with liver metastases, and seven with cholangiocarcinoma (CCC) were included in study. Mean follow-up time was 5.6 ± 7.1 months for HCC, 6.4 ± 5.1 months for metastases, and 10.1 ± 4.8 months for the CCC. Complete response was seen in 4/36 (11.1%) HCCs and 1/25 (4%) metastases. Partial response (>30% decrease in long diameter) was seen in 25/36 (69%) HCCs, 14/25 (58%) metastases, and 7/7 (100%) of CCCs. Partial response followed by local recurrence (>20% increase in long diameter from nadir) occurred in 2/36 (6%) HCCs and 4/25 (17%) metastases. Liver parenchyma adjacent to the lesion demonstrated a prominent halo of delayed enhancement in 27/36 (78%) of HCCs, 19/21 (91%) of metastases, and 7/7 (100%) of CCCs.Conclusion. Sustainable radiological partial response to stereotactic radiotherapy is most frequent outcome seen in liver lesions. Prominent halo of delayed enhancement of the adjacent liver is frequent finding.Keywords
This publication has 28 references indexed in Scilit:
- Évaluation de la réponse thérapeutique après radiothérapie stéréotaxique des lésions tumorales hépatiquesCancer/Radiothérapie, 2014
- Hepatocellular carcinoma: natural history, current management, and emerging toolsBiologics: Targets and Therapy, 2012
- Clinical Outcomes of Stereotactic Radiosurgery in the Treatment of Patients with Metastatic Brain TumorsWorld Neurosurgery, 2011
- Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary ResultsTechnology in Cancer Research & Treatment, 2010
- Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary ResultsHPB Surgery, 2010
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- MR Imaging of Liver Fibrosis: Current State of the ArtRadioGraphics, 2009
- Three-Fraction Stereotactic Body Radiation Therapy for Isolated Liver Recurrence from Colorectal CancerTumori Journal, 2009
- Current controversies in the surgical management of colorectal cancer metastases to the liver.2007
- RADIATION HEPATITIS.1965